The opportunities for this DNA test maker are tremendous. But there are challenges, also.
There haven’t been too many stocks hotter than EXACT Sciences Corporation (NASDAQ:EXAS) over the past couple of years. The molecular diagnostics company enjoyed a fantastic 2017. Since 2016, Exact Sciences’ share price has soared more than 420%.
However, 2018 hasn’t started off so great for the stock. Is Exact Sciences a flash in the pan, or could it potentially be a millionaire-maker stock? Here are the opportunities and challenges that the company faces that should determine the answer to the question.
